Clinical Trial Update: Multi-omics Based Prediction of Treatment Response to Immunotherapy Combined with Chemotherapy in Advanced Gastric/Gastroesophageal Junction Cancer.

View source ↗

Summary

A clinical trial is investigating multi-omics predictors of response to immunotherapy plus chemotherapy in advanced gastric cancer and gastroesophageal junction…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma

Snippet

Sponsor: Xiangdong Cheng | Conditions: Advanced Gastric Carcinoma, Advanced Gastroesophageal Junction Adenocarcinoma | Status: RECRUITING